Changes in well-being and quality of life in a randomized trial comparing dynamic psychotherapy and pharmacotherapy for major depressive disorder

The Derner Institute of Advanced Psychological Studies, Adelphi University, United States. Electronic address: .
Journal of Affective Disorders (Impact Factor: 3.71). 10/2013; 152-154. DOI: 10.1016/j.jad.2013.10.015
Source: PubMed

ABSTRACT Major depressive disorder (MDD) is associated with a decrease in quality of life (QOL) and well-being. Therefore, researchers are increasingly complementing traditional symptom measurements with QOL and well-being assessments in order to broaden the evaluation of treatment outcomes. The current prospective study investigated the effectiveness of supportive-expressive therapy (SET), antidepressant medication (MED) and placebo (PBO) in improving QOL and well-being in patients with MDD.
Data from a randomized controlled trial (trial registration: NCT00043550) comparing SET, MED and PBO for the treatment of depression (N=156) were analyzed. Outcome measures addressed patients' QOL and physical and mental well-being. Changes in outcomes were assessed across and between treatments using linear mixed models.
Across treatments, patients showed significant improvement in QOL and mental and physical health measures, as well as a reduction in interpersonal distress and depressive and anxiety symptoms (p≤.002 for all measures). Those changes were not only the products of a decrease in depressive symptoms, but also predicted subsequent reduction in symptoms. No significant differences were found between the three treatment conditions.
The limitation is the study's moderate sample size.
Current treatments for depression significantly improve patients' QOL and well-being. No significant differences were found between the three conditions examined in this study. The current study highlights the role of well-being in predicting subsequent symptomatic change.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Assessing quality of life (QoL) as a patient-reported outcome in adult psychiatry poses challenges in terms of concepts, methods, and applications in research and practice. This review will outline conceptually the construct of QoL, its dimensionality, and its representation across patient groups. Methodological challenges are examined, along with principles of QoL instrument development and testing, as well as across cultures. Application of instruments in epidemiological, clinical health economics, and health services research is reviewed based on pertinent literature. Validated measures for depression, psychosis, and anxiety disorders are available in adult psychiatry, and are increasingly used in research. Still, targeted measures are lacking for many mental health conditions and only rarely are tools applied in the practice context. Progress has been made in the development of instruments that are now ready for implementation. The information to be gained is valuable for identifying patient-reported needs for and benefits of treatment.
    Dialogues in clinical neuroscience 06/2014; 16(2):137-45.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Die Frage nach der Wirksamkeit psychodynamischer Behandlungsverfahren hat in berufspolitischen und wissenschaftlichen Debatten der letzten Jahre einen hohen Stellenwert eingenommen. In diese Zeit fällt eine Vielzahl weiterer Studienergebnisse mit neuen Effektivitätsnachweisen. Ziel des vorliegenden Beitrags ist es, einen überblick über aktuelle Ergebnisse der psychodynamischen Psychotherapieforschung zu geben, mit einem Schwerpunkt auf Metaanalysen und randomisierten Vergleichsstudien. Die Ergebnisse zeigen, dass es für eine große Anzahl von Störungsbildern mittlerweile Effektivitätsnachweise auf einer robusten Datengrundlage gibt. Die methodische Qualität der aktuellen Studien ist gut; auch der Vergleich mit anderen Therapieverfahren braucht nicht gescheut zu werden. Gleichzeitig sind weitere Studien notwendig, sowohl in Bezug auf Störungsbilder als auch Praxisstudien zur Abbildung der Wirksamkeit in der Breite der Anwendung im Alltag. Abstract The effectiveness of psychodynamic psychotherapy has been a “hot topic” in scientific and healthcare related debates in recent years. During this time a significant amount of new evidence supporting the effectiveness of psychodynamic psychotherapy has been published. The paper provides an overview on current psychodynamic psychotherapy research, with a focus on meta-analytic findings and randomized effectiveness trials. The results in the literature show robust evidence for the effectiveness of psychodynamic therapies for a wide range of psychiatric disorders. The methodological quality of current studies is good and comparative trials with other forms of psychotherapy yield mostly equivalent results. However, further studies are needed with regard to different mental disorders as well as effectiveness studies in everyday practice.
    Psychotherapeut 05/2014; 59(3):212-218. DOI:10.1007/s00278-014-1045-5 · 0.78 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Sigal Zilcha-Mano & Jacques P. Barber Is Psychodynamic Therapy (PTPT) an evidence-based practice? What makes PT work? In the present article we shall discuss empirical evidence for these as well as other vital questions. First, we shall examine the existing findings concerning two of the most widespread myths about PT: (1) PT is not an evidence-based therapy; (2) PT is not directed at and, therefore, not effective at alleviating symptoms. Second, we shall examine some of the existing findings regarding what it is that actually enables change in PT. The aim of the paper is to provide some access to the knowledge accumulated from numerous studies on PT treatments, conducted by dozens of therapists, with the hope that it will benefit clinicians.
    Contemporary psychoanalysis 03/2014; DOI:10.1080/00107530.2014.880309 · 0.33 Impact Factor


Available from
May 31, 2014